| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.53▼ | 4.51▲ | 4.49▲ | 4.07▲ | 4.06▲ |
| MA10 | 4.50▲ | 4.49▲ | 4.44▲ | 4.06▲ | 3.87▲ |
| MA20 | 4.51▲ | 4.35▲ | 4.18▲ | 4.02▲ | 3.76▲ |
| MA50 | 4.39▲ | 4.08▲ | 4.08▲ | 3.80▲ | 3.22▲ |
| MA100 | 4.12▲ | 4.07▲ | 4.05▲ | 3.78▲ | 2.29▲ |
| MA200 | 4.08▲ | 4.05▲ | 3.79▲ | 3.43▲ | 2.80▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.009▲ | 0.039▲ | 0.028▲ | 0.029▲ |
| RSI | 56.069▲ | 66.715▲ | 68.059▲ | 61.128▲ | 62.422▲ |
| STOCH | 84.944▲ | 66.928 | 79.175 | 42.716 | 66.004 |
| WILL %R | -23.913▲ | -25.000▲ | -12.687▲ | -22.751▲ | -11.169▲ |
| CCI | 64.000 | 61.655 | 82.085 | 229.466▲ | 136.317▲ |
|
Thursday, May 14, 2026 01:00 AM
CLEARWATER, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the ...
|
|
Tuesday, May 12, 2026 05:25 PM
Apyx Medical Corp. stock grades by Barron's. View APYX fundamental and sentiment analysis powered by MarketGrader.
|
|
Thursday, May 07, 2026 12:00 AM
Reported total revenue of $12.5 million in the first quarter of 2026 primarily driven by 36% growth in the Surgical Aesthetics segment Raised total revenue guidance for FY2026 to a range of $59.0 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/06/26 | 4.28 | 4.685 | 4.24 | 4.47 | 317,804 |
| 04/06/26 | 3.79 | 4.34 | 3.79 | 4.29 | 535,041 |
| 03/06/26 | 3.83 | 3.915 | 3.75 | 3.79 | 78,899 |
| 02/06/26 | 3.93 | 4.15 | 3.83 | 3.85 | 112,624 |
| 01/06/26 | 4.00 | 4.1466 | 3.87 | 3.96 | 90,750 |
| 29/05/26 | 4.13 | 4.28 | 3.98 | 3.995 | 110,107 |
| 28/05/26 | 3.87 | 4.22 | 3.87 | 4.15 | 98,364 |
| 27/05/26 | 4.09 | 4.09 | 3.86 | 3.90 | 75,480 |
| 26/05/26 | 4.13 | 4.20 | 3.95 | 4.09 | 99,682 |
| 22/05/26 | 4.23 | 4.40 | 4.11 | 4.13 | 127,068 |
|
|
||||
|
|
||||
|
|